Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines
1997

Proteinase Inhibitors and Breast Cancer Cell Invasion

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): PS Stonelake, CE Jones, JP Neoptolemos, PR Baker

Primary Institution: University of Birmingham

Hypothesis

The study aims to establish the relative contributions of different proteinases in the degradation of the basement membrane by breast cancer cells.

Conclusion

Inhibitors of uPA/plasminogen activation and MMPs may be potential therapeutic agents for breast cancer treatment.

Supporting Evidence

  • Proteinase inhibitors reduced basement membrane degradation by 30-40%.
  • BB94, an MMP inhibitor, reduced BMD by about 30% under serum-free conditions.
  • Combinations of proteinase inhibitors showed additive effects in reducing BMD.

Takeaway

This study found that certain proteinase inhibitors can help stop breast cancer cells from breaking down barriers in the body, which might help in treating the disease.

Methodology

The study used in vitro assays with human breast cancer cell lines to measure basement membrane degradation in the presence of various proteinase inhibitors.

Limitations

The study was conducted in vitro, which may not fully replicate in vivo conditions.

Participant Demographics

The study involved human breast cancer cell lines, including MDA-MB-231 and MCF7ADR.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication